Skip to main content
SpringerLink
Log in

Clinical trials report

  • Published:
Current Hypertension Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Dahlof B, Sever PS, Poulter NR, et al.: Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomized controlled trial. For the ASCOT Investigators. Lancet 2005, 366:895–906.

    Article  PubMed  Google Scholar 

  2. Poulter N, Wedel H, Dahlof B, et al.: Role of blood pressure and other variables in the differential cardiovascular event rates noted in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA). For the ASCOT Investigators. Lancet 2005, 366:907–913.

    Article  PubMed  CAS  Google Scholar 

  3. Staessen JA, Birkenhager WH: Evidence that new antihypertensives are superior to older drugs. Lancet 2005, 366:869–870.

    Article  PubMed  Google Scholar 

  4. Chobanian AV, Bakris GL, Black HR, et al.: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report. JAMA 2003, 289:2560–2572.

    Article  PubMed  CAS  Google Scholar 

  5. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002, 288:2981–2997.

    Article  Google Scholar 

  6. Julius S, Kjeldsen SE, Weber M, et al.: Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomized trial. Lancet 2004, 363:2022–2031.

    Article  PubMed  CAS  Google Scholar 

  7. Williams B, The CAFÉ Investigators for the ASCOT Investigators: Differential impact of blood pressure lowering drugs on central aortic pressure and clinical outcomes-Principal results of the Conduit Artery Function Evaluation Study: the CAFÉ study. Circulation 2006, 113:1213–1225.

    Article  PubMed  CAS  Google Scholar 

  8. Morgan T, Lauri J, Bertram D, Anderson A: Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens 2004, 17:118–123.

    Article  PubMed  CAS  Google Scholar 

  9. Lindholm LH, Carlberg B, Samuelsson O: Should betablockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet 2005, 366:1545–1553.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Suzanne Oparil MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oparil, S. Clinical trials report. Current Science Inc 8, 229–231 (2006). https://doi.org/10.1007/s11906-006-0055-2

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11906-006-0055-2

Keywords

Search

Navigation